BRIEF published on 05/06/2026 at 16:41, 2 days 23 hours ago Sartorius réussit l'émission d'obligations de 500 millions d'euros Sartorius Emission D'obligations Confiance Des Investisseurs Refinancement De La Dette Sursouscription Du Marché
BRIEF published on 05/06/2026 at 16:41, 2 days 23 hours ago Sartorius Successfully Issues €500 Million Bond Investor Confidence Sartorius Bond Issuance Debt Refinancing Market Oversubscription
PRESS RELEASE published on 05/06/2026 at 16:36, 2 days 23 hours ago Sartorius completes placement of bond with a volume of 500 million euros Sartorius successfully completes the placement of a 500 million euros bond, oversubscribed more than 4 times, to be used for general corporate purposes and refinancing Refinancing Corporate Finance Sartorius Bond Placement 500 Million Euros
BRIEF published on 04/24/2026 at 11:35, 15 days 4 hours ago Sartorius AG prolonge le mandat de son directeur financier, Florian Funck. Conseil D'administration Sartorius AG Industrie Biopharmaceutique Leadership Financier Florian Funck
BRIEF published on 04/24/2026 at 11:35, 15 days 4 hours ago Sartorius AG Extends CFO Florian Funck's Tenure Executive Board Sartorius AG Biopharmaceutical Industry Financial Leadership Florian Funck
PRESS RELEASE published on 04/24/2026 at 11:30, 15 days 5 hours ago Sartorius AG Supervisory Board extends appointment of board member Florian Funck Sartorius AG extends CFO Florian Funck's term on the Executive Board until 2032. Learn more about Funck's background and Sartorius AG's financial calendar and divisions CFO Executive Board Supervisory Board Sartorius AG Florian Funck
BRIEF published on 04/23/2026 at 07:05, 16 days 9 hours ago Sartorius annonce un bon début d'année 2026 avec une forte croissance de son chiffre d'affaires. Croissance Des Revenus Marge Bénéficiaire Solutions De Bioprocédés Orientations Pour 2026 Division Du Laboratoire
BRIEF published on 04/23/2026 at 07:05, 16 days 9 hours ago Sartorius Reports Strong Start to 2026 with Revenue Growth Revenue Growth Profit Margin Bioprocess Solutions 2026 Guidance Lab Division
PRESS RELEASE published on 04/23/2026 at 07:00, 16 days 9 hours ago Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1% Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
BRIEF published on 03/26/2026 at 16:25, 1 month 14 days ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
Published on 05/09/2026 at 01:30, 15 hours 1 minute ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 16 hours 31 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 19 hours 53 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 21 hours 18 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 21 hours 29 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
